BioAge Labs Appoints BJ Sullivan as Chief Strategy Officer
BioAge Labs, Inc., a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced the appointment of BJ Sullivan, Ph.D., as Chief Strategy Officer.
- BioAge Labs, Inc., a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, today announced the appointment of BJ Sullivan, Ph.D., as Chief Strategy Officer.
- Sullivan is the first to hold the position at BioAge.
- “I am thrilled to announce the promotion of BJ Sullivan to BioAge’s first Chief Strategy Officer.
- In that capacity, he partnered closely with the executive team to define both corporate and program strategy.